BUZZ-India's Dr. Reddy's Labs hits over 1-year low; firm's drug infringes U.S. patents

Last Updated: Thu, Feb 16, 2017 10:20 hrs

** Shares of Dr Reddy's Laboratories fall as much as 3.9 pct, their lowest since Jan 22, 2016

** U.S. court finds the company's anti-nausea drug, palonosetron hydrochlorid, infringes certain U.S. patents

** Company said it intends to pursue an appeal in due course

** Stock among top losers on the broader NSE index

** Stock posts biggest intraday percentage loss since Nov 9, 2016

** About 480,000 shares traded, nearly double the stock's 30-day average volume

** As of Wednesday's close, stock down 4.9 pct this year

More from Sify: